Third Harmonic Bio, Inc.
THRDDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001923840
Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Third Harmonic Bio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +40 vs. Q2 2022
- Shares held
- 35.5M
- +35.5M vs. Q2 2022
- Total value
- $672.8M
- +$672.8M vs. Q2 2022
- New holders
- 40
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $110.0K |
| Q1 2026 | 4 | $110.0K |
| Q4 2025 | 4 | $111.5K |
| Q3 2025 | 18 | $1.19M |
| Q2 2025 | 107 | $210.2M |
| Q1 2025 | 100 | $134.4M |
| Q4 2024 | 98 | $462.5M |
| Q3 2024 | 85 | $596.6M |
| Q2 2024 | 77 | $523.2M |
| Q1 2024 | 71 | $357.6M |
| Q4 2023 | 62 | $416.0M |
| Q3 2023 | 56 | $241.5M |
| Q2 2023 | 48 | $173.5M |
| Q1 2023 | 49 | $149.7M |
| Q4 2022 | 50 | $153.1M |
| Q3 2022 | 40 | $672.8M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Third Harmonic Bio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sandia Investment Management LP | 1,000 | $19.0K | 0.00% | +1,000 | New |
| UBS Group AG | 1,252 | $24.0K | 0.00% | +1,252 | New |
| Royal Bank of Canada | 5,557 | $105.0K | 0.00% | +5,557 | New |
| Morgan Stanley | 7,160 | $136.0K | 0.00% | +7,160 | New |
| Point72 Asset Management, L.P. | 8,000 | $152.0K | 0.00% | +8,000 | New |
| Eversept Partners, LP | 10,000 | $189.7K | 0.02% | +10,000 | New |
| Cubist Systematic Strategies, LLC | 10,561 | $200.0K | 0.00% | +10,561 | New |
| Polar Asset Management Partners Inc. | 11,596 | $220.0K | 0.00% | +11,596 | New |
| Caas Capital Management LP | 16,000 | $304.0K | 0.04% | +16,000 | New |
| Platinum Investment Management Ltd | 17,825 | $338.0K | 0.01% | +17,825 | New |
| Jane Street Group, LLC | 18,809 | $357.0K | 0.00% | +18,809 | New |
| Point72 Hong Kong Ltd | 19,099 | $362.0K | 0.02% | +19,099 | New |
| Manufacturers Life Insurance Company, The | 20,766 | $391.2K | 0.00% | +20,766 | New |
| Two Sigma Investments, LP | 25,000 | $474.0K | 0.00% | +25,000 | New |
| Squarepoint Ops LLC | 25,384 | $482.0K | 0.00% | +25,384 | New |
| Qube Research & Technologies Ltd | 27,800 | $527.0K | 0.00% | +27,800 | New |
| Barclays PLC | 28,750 | $546.0K | 0.00% | +28,750 | New |
| Monashee Investment Management LLC | 40,000 | $759.0K | 0.28% | +40,000 | New |
| Ghisallo Capital Management LLC | 40,000 | $759.0K | 0.10% | +40,000 | New |
| Goldman Sachs Group Inc | 54,500 | $1.03M | 0.00% | +54,500 | New |
| Citadel Advisors LLC | 57,687 | $1.09M | 0.00% | +57,687 | New |
| Marshall Wace, LLP | 58,465 | $1.11M | 0.00% | +58,465 | New |
| Alyeska Investment Group, L.P. | 75,000 | $1.42M | 0.02% | +75,000 | New |
| Vanguard Group Inc | 100,000 | $1.90M | 0.00% | +100,000 | New |
| Millennium Management LLC | 178,301 | $3.38M | 0.00% | +178,301 | New |
| Artal Group S.A. | 200,000 | $3.79M | 0.20% | +200,000 | New |
| Suvretta Capital Management, LLC | 200,000 | $3.79M | 0.16% | +200,000 | New |
| Woodline Partners LP | 200,063 | $3.79M | 0.06% | +200,063 | New |
| Price T Rowe Associates Inc | 470,626 | $8.93M | 0.00% | +470,626 | New |
| Boxer Capital, LLC | 570,417 | $10.8M | 0.61% | +570,417 | New |
| RTW Investments, LP | 609,687 | $11.6M | 0.27% | +609,687 | New |
| Commodore Capital LP | 1,018,569 | $19.3M | 3.11% | +1,018,569 | New |
| Wellington Management Group LLP | 1,168,554 | $22.2M | 0.00% | +1,168,554 | New |
| Deep Track Capital, LP | 1,268,220 | $24.1M | 1.19% | +1,268,220 | New |
| Bain Capital Life Sciences Investors, LLC | 2,280,082 | $43.3M | 5.16% | +2,280,082 | New |
| General Atlantic LLC | 2,958,762 | $56.1M | 0.66% | +2,958,762 | New |
| Ra Capital Management, L.P. | 3,475,687 | $65.9M | 1.41% | +3,475,687 | New |
| BVF Inc | 3,501,814 | $66.4M | 2.74% | +3,501,814 | New |
| OrbiMed Advisors LLC | 5,779,071 | $109.6M | 2.18% | +5,779,071 | New |
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $206.9M | 22.83% | +10,907,859 | New |